Hypolipidemic effects and safety of Lactobacillus Reuteri 263 in a hamster model of hyperlipidemia

Wen Ching Huang, Yi Ming Chen, Nai Wen Kan, Chun Sheng Ho, Li Wei, Ching Hung Chan, Hui Yu Huang, Chi Chang Huang

研究成果: 雜誌貢獻文章

20 引文 斯高帕斯(Scopus)

摘要

We aimed to verify the beneficial effects of probiotic strain Lactobacillus reuteri 263 (Lr263) on hypolipidemic action in hamsters with hyperlipidemia induced by a 0.2% cholesterol and 10% lard diet (i.e., high-cholesterol diet (HCD)). Male Golden Syrian hamsters were randomly divided into two groups: normal (n = 8), standard diet (control), and experimental (n = 32), a HCD. After a two-week induction followed by a six-week supplementation with Lr263, the 32 hyperlipidemic hamsters were divided into four groups (n = 8 per group) to receive vehicle or Lr263 by oral gavage at 2.1, 4.2, or 10.5 × 109 cells/kg/day for 6 weeks, designated the HCD, 1X, 2X and 5X groups, respectively. The efficacy and safety of Lr263 supplementation were evaluated by lipid profiles of serum, liver and feces and by clinical biochemistry and histopathology. HCD significantly increased serum levels of total cholesterol (TC), triacylglycerol (TG) cholesterol, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C), LDL-C/HDL-C ratio, hepatic and fetal TC and TG levels, and degree of fatty liver as compared with controls. Lr263 supplementation dose dependently increased serum HDL-C level and decreased serum TC, TG, LDL-C levels, LDL-C/HDL-C ratio, hepatic TC and TG levels, and fecal TG level. In addition, Lr263 supplementation had few subchronic toxic effects. Lr263 could be a potential agent with a hypolipidemic pharmacological effect.
原文英語
頁(從 - 到)3767-3782
頁數16
期刊Nutrients
7
發行號5
DOIs
出版狀態已發佈 - 五月 15 2015

ASJC Scopus subject areas

  • Food Science

指紋 深入研究「Hypolipidemic effects and safety of Lactobacillus Reuteri 263 in a hamster model of hyperlipidemia」主題。共同形成了獨特的指紋。

  • 引用此